Zobrazeno 1 - 10
of 4 343
pro vyhledávání: '"renal denervation"'
Publikováno v:
Journal of Health, Population and Nutrition, Vol 43, Iss 1, Pp 1-14 (2024)
Abstract Background Renal Denervation (RDN) is a novel non-pharmacological technique to treat hypertension. This technique lowers blood pressure by blocking the sympathetic nerve fibers around the renal artery, then causing a decrease in system sympa
Externí odkaz:
https://doaj.org/article/c4fabcf1831e4c3ca4c2fd2ff25f1a69
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 8, Pp 1154-1159 (2024)
Denervation is closely related to many cardiovascular diseases, such as myocardial infarction, myocardial ischemia-reperfusion injury, hypertension, arrhythmia, heart failure, atherosclerosis and ventricular remodeling. Denervation affects the patien
Externí odkaz:
https://doaj.org/article/adc46bde80d64b47a637fe8314cde789
Autor:
Tatsuya Shiraki, Hiroya Mizuno, Takuya Kishi, Masanori Asakura, Hidetsugu Asanoi, Yoshio Yasumura, Yasushi Sakata
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2426-2431 (2024)
Abstract This case report describes the application of ultrasound renal denervation (uRDN) using the Paradise System in a patient with heart failure with preserved ejection fraction. Initially, the cardiac sympathetic nerve activity of the patient ex
Externí odkaz:
https://doaj.org/article/bd5235dec1a440629f43114e80a9e54c
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 3, Iss 10, Pp 102248- (2024)
Externí odkaz:
https://doaj.org/article/3003c56d57274340a871ca36c0c8c6a4
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 3S (2024)
Introduction. Renovascular hypertension is one of the most severe types of hypertension in terms of the choice of treatment strategy. Recent studies have not provided a clear answer to the question of which treatment approach (conservative or surgica
Externí odkaz:
https://doaj.org/article/ecaa346e4dd848ea94d64001b4ec9b0c
Autor:
Syed Hamza Mufarrih, Nada Qaisar Qureshi, Mohammed Saud Khan, Mohammed Kazimuddin, Eric Secemsky, Michael J. Bloch, Jay Giri, Debbie Cohen, Rajesh V. Swaminathan, Dmitriy N. Feldman, Khaldoon Alaswad, Ajay Kirtane, David Kandzari, Herbert D. Aronow
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 16 (2024)
Background Despite optimal medical therapy, a significant proportion of patients' blood pressure remains uncontrolled. Catheter‐based renal denervation (RDN) has been proposed as a potential intervention for uncontrolled hypertension. We conducted
Externí odkaz:
https://doaj.org/article/7902aeb78e214820ad19b9c4ef00ded9
Autor:
Kazuomi Kario
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 16 (2024)
Externí odkaz:
https://doaj.org/article/f5853152ebd344c58fa3e296b65575d3
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 13-27 (2024)
Abstract Heart failure with preserved ejection fraction (HFpEF) is a group of clinical syndromes that exhibit a remarkably heterogeneous phenotype, characterized by symptoms and signs of heart failure, left ventricular diastolic dysfunction, elevated
Externí odkaz:
https://doaj.org/article/fbc2dc53a0be4212bd1c72430f6ce71b
Publikováno v:
Renal Failure, Vol 46, Iss 2 (2024)
Objective This study aimed to systematically evaluate the effectiveness and safety of renal denervation (RDN) in managing heart failure with reduced ejection fraction (HFrEF).Methods A comprehensive search was done in multiple databases: Cochrane Lib
Externí odkaz:
https://doaj.org/article/d3f0dc0c45344d1684836c04e7e1fb84